FATE THERAPEUTICS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| ABBOT STEWART | Chief Development Officer | Award / Grant | 40,000 | — | — | 40,000 | Oct 15, 2015 |
| Wolchko J Scott | CFO & Chief Operating Officer | Award / Grant | 86,250 | — | — | 121,023 | Oct 15, 2015 |
| Shoemaker Daniel D | Chief Scientific Officer | Award / Grant | 66,000 | — | — | 94,428 | Oct 15, 2015 |
| Wolchko J Scott | See Remarks | Option Exercise | 2,936 | $1.63 | $4,786 | 34,773 | Apr 13, 2015 |
| Weyer Christian | See Remarks | Option Exercise | 25,000 | $1.37 | $34,250 | 30,429 | Apr 13, 2015 |
| Flynn Peter D | See remarks | Award / Grant | 2,466 | — | — | 6,505 | Jan 5, 2015 |
| Shoemaker Daniel D | Chief Research Officer | Award / Grant | 2,466 | — | — | 28,428 | Jan 5, 2015 |
| Multani Pratik S | Chief Medical Officer | Award / Grant | 3,024 | — | — | 3,024 | Jan 5, 2015 |
| Wolchko J Scott | See remarks | Award / Grant | 2,885 | — | — | 26,773 | Jan 5, 2015 |
| Weyer Christian | See remarks | Award / Grant | 5,429 | — | — | 5,429 | Jan 5, 2015 |
| Flynn Peter D | See remarks | Option Exercise | 1,017 | $1.63 | $1,658 | 5,056 | Jun 12, 2014 |
| Flynn Peter D | See remarks | Sale | 1,955 | $7.00 | $13,685 | 4,690 | Jun 9, 2014 |
| Flynn Peter D | See remarks | Option Exercise | 1,100 | $1.63 | $1,793 | 14,756 | May 1, 2014 |
| Flynn Peter D | See remarks | Sale | 100 | $8.69 | $869 | 6,731 | Apr 4, 2014 |
| Wolchko J Scott | See remarks | Option Exercise | 8,862 | $1.37 | $12,141 | 23,888 | Apr 3, 2014 |
| Weyer Christian | See remarks | Option Exercise | 2,262 | $1.37 | $3,099 | 2,262 | Apr 1, 2014 |
| Wolchko J Scott | See remarks | Sale | 500 | $10.64 | $5,320 | 19,045 | Mar 31, 2014 |
| Flynn Peter D | See remarks | Sale | 1,346 | $9.05 | $12,181 | 6,731 | Mar 31, 2014 |
| Shoemaker Daniel D | Chief Technology Officer | Sale | 400 | $10.57 | $4,228 | 25,962 | Mar 31, 2014 |
| MENDLEIN JOHN | — | Purchase | 16,667 | $6.00 | $100,002 | 156,774 | Oct 4, 2013 |
| RASTETTER WILLIAM H | — | Purchase | 83,333 | $6.00 | $499,998 | 83,333 | Oct 4, 2013 |
| NELSEN ROBERT | — | C | 265,252 | — | — | 1,511,408 | Oct 4, 2013 |
| BYBEE CLINTON | — | Purchase | 833,333 | $6.00 | $4,999,998 | 2,473,188 | Oct 4, 2013 |
| OVP VENTURE PARTNERS VII LP | — | C | 702,387 | — | — | 1,372,342 | Oct 4, 2013 |
| Nashat Amir | — | Purchase | 8,041 | $6.00 | $48,246 | 2,473,186 | Oct 4, 2013 |
| Polaris Venture Partners Special Founders' Fund V, L.P. | — | Purchase | 8,041 | $6.00 | $48,246 | 2,473,186 | Oct 4, 2013 |
| Venrock Management V, LLC | — | Purchase | 833,333 | $6.00 | $4,999,998 | 2,473,187 | Oct 4, 2013 |